Literature DB >> 8286645

Multiple sclerosis and hepatitis B vaccination.

J P Nadler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8286645     DOI： 10.1093/clinids/17.5.928-b

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

Review 1.  [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Authors:  M Löbermann; B Handorn; A Winkelmann; E C Reisinger; H P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 2.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Safety of tetanus vaccination in relapsing-remitting multiple sclerosis.

Authors:  J De Keyser
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 7.455

Review 4.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

Review 5.  Tracing environmental markers of autoimmunity: introducing the infectome.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Lazaros Sakkas; Shideh Pouria; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.